Omega Blood Count - The optimal measure of Omega-3 and Omega-6 fatty acids
Login    Register

Omega Heart

The underlying cause of heart disease is inflammation in the lining of the arteries. The atheromatous plaques develop on the inflamed areas of arteries. Reducing inflammation is key to prevention of heart disease. Omega-3 is a very important natural anti-inflammatory agent which helps to prevent heart disease by reducing inflammation in the arteries. In a study of 14,916 American doctors who were followed for 17 years, those who had the highest level of Omega-3 at the beginning of the study had a 90% reduced risk of sudden cardiac death(1). This incredible result was confirmed in an Italian study where over 11,000 patients who had had a heart attack were given either an Omega-3 capsule or an olive oil placebo. Those taking the Omega-3 treatment were 45% less likely to have a sudden cardiac death than the control group(2). This study led by the National Institute of Clinical Excellence (NICE) recommended Omega-3 for patients in the UK following a heart attack(3).

Japan has one of the lowest rates of heart disease in the world, largely due to the high Omega-3 intake from their diet which is traditionally high in oily fish. The average Japanese citizen consumes an extra 1g of EPA per day than those in west, which equates to six Fish Oil capsules per day. Despite this healthy diet, heart disease still occurs. In a study of 18,000 Japanese heart patients who were already being treated with statins, those who added 1g of EPA to their diet had an almost 20% reduction in heart disease(4). In a direct comparison with other cholesterol reducing drugs including the famous statins, Omega-3 were the most effective of all those studied in reducing heart attacks and deaths(5).


(1).AlbertCM,CamposH, StampferMJ, et al. Blood levels of long-chain nā€“3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113ā€“8.
(2). GISSI-Prevenzione Investigators Dietary supplementationwith n-3 polyunsaturated fatty acids and vitamin E aftermyocardial infarction: results of theGISSI-Prevenzione trial The Lancet, Volume 354, Issue 9177, Pages 447 ā€“ 455, 7August 1999.
(3). NICE ā€“ Secondary prevention Post MI May 2007.
(4). Yokoyama M, Origasa H; JELIS Investigators. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J. 2003;146:613-620.
(5). Studer,M., et al. Effect of different antilipidemic agents and diets onmortality: a systematic review.Arch. Intern.Med. 165: 725-30, 2005.